Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating efficacy and safety of AK111 in active Ankylosing Spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• AK111

Snippet

Sponsor: Akeso | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED